Demetrix nabs $50 mln Series A
Emeryville, California-based Demetrix Inc, a biotechnology company focused on the production of cannabinoids, has secured $50 million in Series A funding. Tuatara Capital led the round with participation from return backer Horizons Ventures.
11 July 2019•1 min read
